Euclid Systems Corp.
Biotechnology ResearchVirginia, United States0-1 Employees
Euclid Systems Corp. operates in the biotechnology research space with a focus on ophthalmic devices and therapies. Its flagship product is a commercial orthokeratology lens worn overnight that temporarily reduces myopia and aims to slow its progression for individuals seeking non-surgical correction. The company is pursuing additional ocular health innovations, including a sustained-release ophthalmic drug delivery system and a biologic crosslinker in development. Based in Herndon, Virginia, United States, it appears to be operated by a very small team. In 2021, Euclid Systems announced the launch of the Max orthokeratology lens, a product designed for overnight wear to reshape the cornea for temporary myopia reduction.